Showing 1 - 5 results of 5 for search 'Virginie Jakob', query time: 0.02s
Refine Results
-
1
Enhancing Immunogenicity of a Thermostable, Efficacious SARS-CoV-2 Vaccine Formulation through Oligomerization and Adjuvant Choice by Mohammad Suhail Khan, Virginie Jakob, Randhir Singh, Raju S. Rajmani, Sahil Kumar, Céline Lemoine, Harry Kleanthous, Rajesh P. Ringe, Patrice M. Dubois, Raghavan Varadarajan
Published 2023-12-01
Article -
2
The Immunogenicity of Capsid-Like Particle Vaccines in Combination with Different Adjuvants Using Different Routes of Administration by Christoph M. Janitzek, Philip H. R. Carlsen, Susan Thrane, Vijansh M. Khanna, Virginie Jakob, Christophe Barnier-Quer, Nicolas Collin, Thor G. Theander, Ali Salanti, Morten A. Nielsen, Adam F. Sander
Published 2021-02-01
Article -
3
Enhanced protective efficacy of a thermostable RBD-S2 vaccine formulation against SARS-CoV-2 and its variants by Nidhi Mittal, Sahil Kumar, Raju S. Rajmani, Randhir Singh, Céline Lemoine, Virginie Jakob, Sowrabha BJ, Nayana Jagannath, Madhuraj Bhat, Debajyoti Chakraborty, Suman Pandey, Aurélie Jory, Suba Soundarya SA, Harry Kleanthous, Patrice Dubois, Rajesh P. Ringe, Raghavan Varadarajan
Published 2023-10-01
Article -
4
Author Correction: Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses by Christopher L. D. McMillan, Stacey T. M. Cheung, Naphak Modhiran, James Barnes, Alberto A. Amarilla, Helle Bielefeldt-Ohmann, Leo Yi Yang Lee, Kate Guilfoyle, Geert van Amerongen, Koert Stittelaar, Virginie Jakob, Celia Lebas, Patrick Reading, Kirsty R. Short, Paul R. Young, Daniel Watterson, Keith J. Chappell
Published 2022-01-01
Article -
5
Characterization and comparison of novel adjuvants for a prefusion clamped MERS vaccine by Jake S. O’Donnell, Jake S. O’Donnell, Ariel Isaacs, Ariel Isaacs, Virginie Jakob, Celia Lebas, James B. Barnes, Patrick C. Reading, Patrick C. Reading, Paul R. Young, Paul R. Young, Paul R. Young, Daniel Watterson, Daniel Watterson, Daniel Watterson, Patrice M. Dubois, Nicolas Collin, Keith J. Chappell, Keith J. Chappell, Keith J. Chappell
Published 2022-09-01
Article